Board changes at Benitec, Ventracor, BioDiem
Thursday, 17 February, 2005
The management changes at RNAi player Benitec (ASX:BLT) continued yesterday, with the announcement that company secretary Gary Taylor had resigned as a director of the company. Taylor will remain company secretary.
Ventracor (ASX:VCR) has appointed medical devices executive Peter Crosby as chief operating officer. Crosby -- an Australian who has served as CEO of four international medical device companies -- will take on the marketing, sales and distribution of Ventracor's VentAssist device.
BioDiem (ASX:BDM) has appointed former Deutsche Bank executive Andrew O'Brien to its board as a non-executive director. O'Brien headed the Australian healthcare corporate finance at Deutsche Bank, and currently works for consulting firm BioIncyte.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
